High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy

Journal of Neuroscience Research

Volumn 84, Issue 5, 2006, Pages 1085-1090

  Comín, Romina ^a   Yuki, Nobuhiro ^b   Lopez, Pablo H H ^a   Nores, Gustavo A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Affinity; Anti GM 1 antibody; Gangliosides; GM1; Guillain Barr syndrome

Indexed keywords

GM1 ANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBODY AFFINITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GUILLAIN BARRE SYNDROME; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BINDING SITES, ANTIBODY; CATTLE; CHROMATOGRAPHY, THIN LAYER; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; G(M1) GANGLIOSIDE; GUILLAIN-BARRE SYNDROME; RABBITS; TIME FACTORS;

EID: 33749468833     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21004     Document Type: Article

References (37)

1. Arasaki K, Kusoniki S, Kudo N, Kanasawa I. 1993. Acute conduction block in vitro following exposure to anti-ganglioside sera. Muscle Nerve 16:587-593.
2. Cumar FA, Barra HS, Maccioni HJ, Caputto R. 1968. Sulfation of glycosphingolipids and related carbohydrates by brain preparation from young rats. J Biol Chem 246:5075-5084.
3. Dasgupta S, Yu RK. 2004. Lack of apparent neurological abnormalities in rabbits sensitized by gangliosides. Neurochem Res 29:2147-2152.
4. Folch-Pi J, Lees M, Sloane Stanley GM. 1957. A simple method for the insolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509.
5. Harris JR, Markl J. 1999. Keyhole limpet hemocyanin (KLH): a biomedical review. Microm 30:597-623.
6. Hirabayashi Y, Susuki T, Susuki Y, Taki T, Matsumoto M, Higashi H, Kato S. 1983. A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J Biochem 94:327-330.
7. Ilyas AA, Willinson HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, Griffin DE, Griffin JW, McKhann GM. 1988. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 23:440-447.
8. Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. 1998. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology 51: 234-237.
9. 1 antibodies. Ann Neurol 35:234-237.
10. 1b IgG is required to induce rabbit ataxic neuropathy. Ann Neurol 45:400-403.
11. 1 IgM-antibody populations defined by affinity and fine specificity in patients with motor syndromes: evidence for their random origin. J Neuroimmunol 119:131-136.
12. 1 antibodies: comparative characterization of experimentally-induced vs. disease-associated antibodies. J Neuroimmunol 128:69-76.
13. Mizutamari RK, Wiegandt H, Nores GA. 1994. Characterization of antiganglioside antibodies present in normal human plasma. J Neuroimmunol 50:215-220.
14. Musselli C, Livingston PO, Ragupathi G. 2001. Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience. J Cancer Res Clin Oncol 127:R20-R26.
15. Nagai Y, Momoi T, Saito M, Mitsuzawa E, Ohtani S. 1976. Ganglioside Syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett 2:107-111.
16. 1. J Immunol 113:84-93.
17. Nores GA, Dennis RD, Helling F, Wiegandt H. 1991. Human heterophile antibodies recognizing epitopes present on insect glycolipids. J Biochem 110:1-8.
18. Nores GA, Mizutamari RK, Kremer DM. 1994. Chromatographic tank designed to obtain highly reproducible high-performance thin-layer chromatograms of gangliosides and neutral glycosphingolipids. J Chromatogr A686:155-157.
19. 1 antibodies. J Neurol Sci 109:200-206.
20. Panzetta P, Gravotta D, Maccioni H. 1987. Biosynthesis and expression of gangliosides during differentiation of chick embryo retina cells in vitro. J Neurochem 49:1763-1771.
21. Press R, Mata S, Lolli F, Zhu J, Andersson T, Link H. 2001. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barre syndrome. J Neurol Sci 190: 41-47.
22. Steward MW, Steensgaard J. 1983. Antibody affinity: thermodynamic aspect and biological significance. Boca Raton, FL: CRC Press.
23. Susuki K, Nishiraoto Y, Yamada M, Baba M, Ueda S, Hirata K, Yuki N. 2003. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol 54:383-388.
24. Susuki K, Nishimoto Y, Koga M, Nagashima T, Mori I, Hirata K, Yuki N. 2004. Various immunization protocols for an acute motor axonal neuropathy rabbit model compared. Neurosci Lett 368:63-67.
25. + currents in isolated rat myelinated nerve fibers. Ann Neurol 37:436-442.
26. 1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol 82:378-383.
27. 1 IgG antibodies induce leukocyte effector functions via Fc gamma receptors. Ann Neurol 53:570-579.
28. Watanabe K, Arao Y. 1981. A new solvent system for the separation of neutral glycosphingolipids. J Lipid Res 22:1020-1026.
29. 1 antibodies can block neuronal voltage-gated sodium channels. Muscle Nerve 23:1414-1420.
30. Williams MA, McCluer RH. 1980. The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J Neurochem 35:266-269.
31. Wirguin I, Suturkova-Milosevich L, Briani C, Latov N. 1995. Keyhole limpet hemocyanin contains Gal(β1-3)-GalNAc determinate that are cross reactive with the T-antigen. Cancer Immunol Immunother 40:307-310.
32. 1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides. J Neuroimmunol 78:138-142.
33. Yu RK, Ledeen RW. 1972. Gangliosides of human, bovine and rabbit plasma. J Lipid Res 13:680-687.
34. 1 antibodies following Campylobacter enteritis. Neurology 40:1900-1902.
35. 1 ganglioside-like structure. J Exp Med 178: 1771-1775.
36. 1 ganglioside. Ann Neurol 49:712-720.
37. 1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci U S A 101:11404-11409.